x
ServiziMenu principaleHome
You are here: Home > WOF > Past editions > WOF 2018
Print

World Oncology Forum® 2018

The World Oncology Forum Taskforce met on November 1-2, 2018 to address the questions discussed at the previous meetings. We identified three reasons to be hopeful: efforts to address non-communicable diseases are being taken increasingly seriously by governments and policy makers; the concept of universal health coverage is gaining traction; and global health discussions have moved on from focusing on prevention and treating simple conditions, to include the need to invest in diagnostic infrastructures to promote early and accurate diagnosis.

Yet until they move on further, to include investing in treatments for people who are diagnosed with cancer, we will continue to lose the war in the real world.

In the run up to the 2019 UN High Level Summit on Universal Health Coverage, the WOF Taskforce is compiling evidence on the cost-effectiveness of providing cancer care. We can show that investing in radiotherapy capacity gives an impressive return on investment over 20 years, even in the poorest countries, and that extending the bare essentials of surgical capacity to cover key cancer procedures can be made affordable and quickly lead to savings. As for access to effective new drugs, we can point to evidence from the Global Fund to fight AIDS, Tuberculosis and Malaria, which shows that introducing the principles of transparency, benchmarking and pooled purchasing helps lower prices very significantly, while protecting quality and access to a variety of drugs, diagnostics and other technologies.

The WHO has already taken the important step of adopting ESMO’s Magnitude of Clinical Benefit Scale to screen new cancer drugs for inclusion in its Essential Medicines List. We now need to convince governments and policy makers of the economic as well as humanitarian strengths of our case for coordinated action on cancer, as part of the global universal healthcare efforts. Every one of us in the cancer community can help make that happen.




Participants

Matti Aapro, Clinique de Genolier, Switzerland
Bassim Al Bahrani, National Oncology Center, Oman
Nicholas Anthony Othieno Abinya, University of Nairobi, Kenya
Sanchia Aranda, Cancer Council Australia, Australia
Rifat Atun, Harvard University, USA
Franco Cavalli, European School of Oncology, Switzerland
Alberto Costa, European School of Oncology, Italy and Switzerland
Elisabeth De Vries, Groningen University Hospital, The Netherlands
Alexandru Eniu, Cancer Institute “Ion Chiricuta”, Romania
Felicia Knaul, University of Miami, USA
Antonio Tito Fojo, Columbia University, USA
Mary K. Gospodarowicz, Princess Margaret Cancer Center – University of Toronto, Canada
Nicola Magrini, World Health Organization, Switzerland
Sania Nishtar, Heartfile, Pakistan
Fedro Peccatori, European School of Oncology, Italy
You-Lin Qiao, National Cancer Center, China
Rengaswamy Sankaranarayanan, International Agency for Research on Cancer, France
Richard Sullivan, King’s Comprehensive Cancer Centre, UK

Observers

Fabrizio Barazzoni, ESOF Foundation, Switzerland
Giorgio Noseda, ESOF Foundation, Switzerland
Sandro Rusconi, ESOF Foundation, Switzerland
Pietro Presti, FFO Foundation, Italy
Anna Wagstaff, Cancer World Magazine, UK
Lorenza Wyder, ESOF Foundation, Switzerland

Programme

  1 November 2018
 
 12:30   Standing lunch              
 14:00   Franco Cavalli and Rifat Atun: Welcome and introductions
 14:30   Problems, progress and prospects (1)
Sania Nishtar: UN High Level Meeting on NCDs (via Skype)
 15:30   Coffee break
    Problems, progress and prospects (2)
Moderator: Franco Cavalli
Sania Nishtar: 5’ + 10’ Q&A (via Skype)

Problems
• Systemic treatment (Elisabeth de Vries)
• Radiotherapy (Mary Gospodarowicz)
• Surgery (Richard Sullivan)
• Palliative care (Felicia Knaul)
• Health workforce (Sanchia Aranda)
• Medicines (Nicola Magrini)
• Financing (Rifat Atun)
• South Asia / India (Rengaswamy Sankaranarayanan)
• Africa (Nicholas Abinya)
• Europe (Alexandru Eniu)
• Middle East (Bassim Al Bahrani)
• SE Asia/ China (You-Lin Qiao)
19:30   Aperitif
20:00   Dinner, Sala Veronesi
     
  2 November 2018
     
9:30   Problems, progress and prospects (3) 5’ + 10’ Q&A
Moderator: Franco Cavalli

Progress
• Systemic treatment (Elisabeth de Vries)
• Radiotherapy (Mary Gospodarowicz)
• Surgery (Richard Sullivan)
• Palliative care (Felicia Knaul)
• Health workforce (Sanchia Aranda)
• Medicines (Nicola Magrini)
• Financing (Rifat Atun)
• S Asia / India (Rengaswamy Sankaranarayanan)
• Africa (Nicholas Abinya)
• Europe (Alexandru Eniu)
• Middle East (Bassim Al Bahrani)
• SE Asia/China (You-Lin Qiao)
10:30   Coffee break
11:00   Problems, progress and prospects (4) 5’ + 10’ Q&A
Moderator: Franco Cavalli

Prospects
• Systemic treatment (Elisabeth de Vries)
• Radiotherapy (Mary Gospodarowicz)
• Surgery (Richard Sullivan)
• Palliative care (Felicia Knaul)
• Health workforce (Sanchia Aranda)
• Medicines (Nicola Magrini)
• Financing (Rifat Atun)
• Initiatives in Asia (Rengaswamy Sankaranarayanan)
• Initiatives in Africa (Nicholas Abinya)
• Initiatives in Europe (Alexandru Eniu)
• Initiatives in the Middle East (Bassim Al Bahrani)
• Belt & Road Initiative (You-Lin Qiao)
• World Cancer Congress 2020 (Bassim Al Bahrani)
13:00   Standing lunch
14:00   How can WOF Expert Group best contribute to the fight against cancer
Moderated group discussion
Moderator: Rifat Atun
15:30   Coffee break
16:00   Meeting summary and the next steps
Moderator: Rifat Atun
19:45   Transfer to Restaurant Hotel Scià on Martin
20:00   Dinner Restaurant Hotel Scià on Martin

 

Follow us